Reversal effect of itraconazole on adriamycin and etoposide resistance in human leukemia cells

Annals of Hematology

Volumn 72, Issue 1, 1996, Pages 17-21

  Kurosawa, M ^a   Okabe, M ^a   Hara, N ^a   Kawamura, K ^a   Suzuki, S ^a   Sakurada, K ^a   Asaka, M ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

Author keywords

Adriamycin; Etoposide; Itraconazole; Multidrug resistance; P glycoprotein

Indexed keywords

DOXORUBICIN; ETOPOSIDE; GLYCOPROTEIN P; ITRACONAZOLE; MESSENGER RNA;

ARTICLE; CELL STRAIN HL 60; CELL STRAIN K 562; CONTROLLED STUDY; HUMAN; HUMAN CELL; LEUKEMIA CELL; MULTIDRUG RESISTANCE; PRIORITY JOURNAL;

EID: 0030030061     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00663011     Document Type: Article

References (17)

1. Schinkel AH. Borst P (1991) Multidrug resistance mediated by P-glycoproteins. Semin Cancer Biol 2:213-226
2. Nooter K, Sonneveld P (1994) Clinical relevance of P-glycoprotein expression in hematological malignancies. Leukemia Res 18:233-243
3. Gupta S, Kim J, Gollapudi S (1991) Reversal of daunorubicin resistance in P388/ADR cells by itraconazole. J Clin Invest 87:1467-1469
4. Vreugdenhil G, Raemaekers JMM, van Dijke BJ, de Pauw BE (1993) Itraconazole and multidrug resistance: possible effects on remission rate and disease-free survival in acute leukemia. Ann Hematol 67:107-109
5. Okabe M, Matsushima S, Morioka M, Kobayashi M, Abe S, Sakurada K, Kakinuma M, Miyazaki T (1987) Establishment and characterization of a cell line, TOM-1, derived from a patient with Philadelphia chromosome-positive acute lymphocytic leukemia. Blood 69:990-998
6. 1-positive ALL cell line (ALL/MIK) presenting bcr rearrangement on bcr-2and ALL-type bcr/abl transcript: suggestion of in vitro differentiation to monocytoid lineage. Leuk Lymphoma 12.287-296
7. 1-positive chronic myeloid leukemia cell une MC3 with trilineage phenotype and an altered p53 gene. Leuk Lymphoma 16:493-503
8. Bodner AJ, Tsai S, Ting RC, Collins SJ, Gallo RC (1980) Isolation and characterization of thioguanosine resistant human promyelocytic leukemia cells. Leuk Res 4:151-154
9. 1-positive leukemia cell growth. Blood 80:1330-1338
10. Kunieda Y, Okabe M, Kurosawa M, Itaya T, Kakinuma M, Miyazaki T (1994) Chronic myeloid leukemia presenting ALL-type BCR/ABL transcript. Ann Hematol 69:189-193
11. Noonan KE, Beck C, Holzmayer TA, Chin JE, Wunder JS, Andrulis IL, Gazdar AF, Willman CL, Griffith B, Von Hoff DD, Roninson IB (1990) Quantitative analysis of MDR1 (multidrug resistance) gene expression in human tumors by polymerase chain reaction. Proc Natl Acad Sci USA 87:7160-7164
12. Sugawara I, Watanabe M, Masunaga A, Itoyama S, Ueda K (1992) Primer-dependent amplification of mdr1m RNA by polymerase chain reaction. Jpn J Cancer Res 83:131-133
13. Abbazadegan MR, Futsher BW, Klimecki WT, List A, Dalton WS (1994) Analysis of multidrug resistance-associated protein (MRP) messenger RNA in normal and malignant hematopoietic cells. Cancer Res 54:4676-4679
14. Harker WG, Slade DL, Parr RL, Feldhoff PW, Sullivan DM, Holguin MH (1995) Alteration in the topoisomerase IIα gene, messenger RNA, and subcellular protein distribution as well as reduced expression of the DNA topoisomeras IIβ enzyme in a mitoxantrone-resistant HL-60 human leukemia cell line. Cancer Res 55:1707-1716
15. Tsuruo T, Iida H, Tsukagoshi S, Sakurai Y (1981) Overcoming of vincristine resistance in P388 leukemia in vitro and in vivo through enhanced cytotoxicity of vincristine and vinblastine by verapamil. Cancer Res 41:1967-1972
16. Nooter K, Oostrum R, Jonker R, Dekken H van, Stokdiji W, Engh G van den (1989) Effect of cyclosporin A on daunorubicin accumulation in multidrug-resistant P388 leukemia cells measured by real-time flow cytometry. Cancer Chemother Pharmacol 23:296-300
17. Cimoli G, Valenti M, Parodi S, De Sessa F, Russo P (1994) Circumvention of atypical multidrug resistance with tumor necrosis factor. Jpn J Cancer Res 85:135-138